0033 GMT - In vitro fertilization specialist Monash IVF's profit warning today didn't surprise Ord Minnett much. Monash IVF today said it now expects an FY 2025 underlying net profit of some A$27.5 million, down from guidance of A$30.0 million-A$31.0 million given to investors in late February. Analyst Tom Godfrey said Monash IVF had signaled a subdued outlook at its 1H result and recent Medicare data have been weak. "While we expect medium-term consensus downgrades and a weaker share price today, we note that the updated FY 2025 P/E is 12x suggesting some of this had already been priced in," Ord Minnett says. Monash IVF falls 11% to A$0.76. (david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
May 19, 2025 20:33 ET (00:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.